April 7, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of glipizide 2.5-mg extended-release tablets for the management of type 2 diabetes; zidovudine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results